KRT6C and pancreatic neoplasm: Indeed, there are extremely few high-quality mechanistic studies on other signature genes (e.g., CSTF2, APOM, and KRT6C) that may serve as targets for subsequent studies on the molecular mechanisms of pancreatic cancer.